Literature DB >> 9595017

Demographic characteristics, unreported risk behaviors, and the prevalence and incidence of viral infections: a comparison of apheresis and whole-blood donors. The Retrovirus Epidemiology Donor Study.

S A Glynn1, G B Schreiber, M P Busch, S H Kleinman, A E Williams, C C Nass, H E Ownby, J W Smith.   

Abstract

BACKGROUND: The demographics, deferrable risk behaviors, and the prevalence and incidence of viral infections of apheresis (PH) and whole-blood (WB) donors were compared, to characterize these two populations and to evaluate the relative safety of PH and WB donors in terms of transfusion-transmitted viral infections. STUDY DESIGN AND METHODS: A comparison was made of 36,119 PH donors (> or = 1 PH donation) and 1.38 million WB donors (> or = 1 WB donation) in terms of demographics and the prevalence (/100,000 donors) and incidence (/100,000 person-years) of viral infections, by using data collected at five United States blood collection centers between 1991 and 1994. Deferrable risk behaviors were defined as those risk behaviors that would have resulted in donor deferral, had they been reported. The prevalence of deferrable risk behaviors was estimated by using data collected through an anonymous mail survey.
RESULTS: PH donors were older and more likely than repeat (2+ donations) WB donors to be female, white, and United States-born and to have a higher degree of education (p < or = 0.001). The prevalence of any viral infection was 50 percent higher in WB donors than in PH donors (p = 0.04), whereas the incidence of HIV, human T-lymphotropic virus, and hepatitis B surface antigen was nonsignificantly higher in WB donors. The prevalence of deferrable risk behaviors did not differ in the two groups.
CONCLUSION: Further studies will be needed to evaluate whether the difference in the prevalence of viral infections observed in this study can be explained by demographic characteristics and patterns of donation frequency.

Entities:  

Mesh:

Year:  1998        PMID: 9595017     DOI: 10.1046/j.1537-2995.1998.38498257373.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Safety and availability of immunoglobulin replacement therapy in relation to potentially transmissable agents. IUIS Committee on Primary Immunodeficiency Disease. International Union of Immunological Societies.

Authors:  H M Chapel
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

2.  Demographics of successful, unsuccessful and deferral visits at six blood centers over a 4-year period.

Authors:  Brian Custer; Karen Schlumpf; Toby L Simon; Bryan R Spencer; David J Wright; Susan L Wilkinson
Journal:  Transfusion       Date:  2011-09-26       Impact factor: 3.157

3.  HIV in the United States at the turn of the century: an epidemic in transition.

Authors:  J M Karon; P L Fleming; R W Steketee; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

4.  Anti-HBc screening in Indian blood donors: still an unresolved issue.

Authors:  Hari-Krishan Dhawan; Neelam Marwaha; Ratti-Ram Sharma; Yogesh Chawla; Beenu Thakral; Karan Saluja; Sanjeev-Kumar Sharma; Manish-K Thakur; Ashish Jain
Journal:  World J Gastroenterol       Date:  2008-09-14       Impact factor: 5.742

5.  Relationship between social capital and test seeking among blood donors in Brazil.

Authors:  C D L Oliveira; T Goncalez; D Wright; P C Rocha; C Miranda; L Capuani; A B Carneiro-Proietti; F A Proietti; C de Almeida-Neto; N M Larsen; D Sampaio; B Custer
Journal:  Vox Sang       Date:  2012-08-15       Impact factor: 2.144

6.  The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.

Authors:  Steven Kleinman; Melissa R King; Michael P Busch; Edward L Murphy; Simone A Glynn
Journal:  Transfus Med Rev       Date:  2012-05-24

7.  The need to label red blood cell units with their haemoglobin content: a single centre study on haemoglobin variations due to donor-related factors.

Authors:  Naveen Agnihotri; Lokesh Pal; Manish Thakur; Pravin Kumar
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

8.  The estimation of prevalence, incidence, and residual risk of transfusion-transmitted human hepatitis B infection from blood donated at the Anhui blood center, China, from 2009 to 2011.

Authors:  Wuping Li; Zhan Gao; Chunhui Yang; Jiahu Li; Ling Li; Rong Lv; Zhong Liu
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.